Shalkami A S, Hassan Mia, Bakr A G
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
Hum Exp Toxicol. 2018 Jan;37(1):78-86. doi: 10.1177/0960327117694075. Epub 2017 Feb 23.
UNLABELLED: Ulcerative colitis (UC) is a chronic inflammatory disease affecting colon. The primary symptoms of UC are diarrhoea with blood and mucus and sometimes associated with pain. AIM: This study aimed to evaluate the effects of diosmin (DIO) on UC. METHODS: UC was induced in rats by rectal administration of acetic acid (AA). The degree of mucosal ulceration and damage was determined by evaluating the disease activity index (DAI) and colon damage index scores. Inflammation, oxidative stress and apoptotic responses were determined by measuring the levels of tumour necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-II), malondialdehyde (MDA) and reduced glutathione (GSH) in addition to myeloperoxidase (MPO) activity and caspase-3 expression. RESULTS: The results of this study indicate that AA caused increase in DAI and colon damage index scores. Also, markers of inflammation (TNF-α, COX-II and MPO) and oxidative stress (MDA and reduced GSH) were significantly elevated. These changes were associated with increases in colon caspase-3 expression. Treatment of rats with two doses of DIO produced a dose-dependent decline in DAI and colon damage index scores. Also, DIO resulted in significant reduction of inflammatory and oxidative stress markers as well as reduced the expression of caspase-3. CONCLUSION: DIO therapy decreased UC development depending on its ability to decreases inflammation, oxidative stress and apoptosis in rat colon.
未标记:溃疡性结肠炎(UC)是一种影响结肠的慢性炎症性疾病。UC的主要症状是伴有血液和黏液的腹泻,有时还伴有疼痛。 目的:本研究旨在评估地奥司明(DIO)对UC的影响。 方法:通过直肠注射乙酸(AA)诱导大鼠患UC。通过评估疾病活动指数(DAI)和结肠损伤指数评分来确定黏膜溃疡和损伤的程度。除了髓过氧化物酶(MPO)活性和半胱天冬酶-3表达外,还通过测量肿瘤坏死因子-α(TNF-α)、环氧化酶-2(COX-II)、丙二醛(MDA)和还原型谷胱甘肽(GSH)的水平来确定炎症、氧化应激和凋亡反应。 结果:本研究结果表明,AA导致DAI和结肠损伤指数评分增加。此外,炎症标志物(TNF-α、COX-II和MPO)和氧化应激标志物(MDA和还原型GSH)显著升高。这些变化与结肠半胱天冬酶-3表达增加有关。用两剂DIO治疗大鼠可使DAI和结肠损伤指数评分呈剂量依赖性下降。此外,DIO可显著降低炎症和氧化应激标志物,并降低半胱天冬酶-3的表达。 结论:DIO治疗可降低UC的发展,这取决于其降低大鼠结肠炎症、氧化应激和凋亡的能力。
Clin Exp Pharmacol Physiol. 2021-5
Wiley Interdiscip Rev RNA. 2025
Sci Rep. 2025-5-17
Inflammopharmacology. 2025-3-31
Food Sci Nutr. 2024-6-18
Front Plant Sci. 2024-10-18
Naunyn Schmiedebergs Arch Pharmacol. 2025-1